---
category: news
title: "Anavex surges 40% as drug improves cognitive function in Alzheimer's patients, meets trial's goals"
excerpt: "Anavex Life Sciences (NASDAQ:AVXL) said its oral drug ANAVEX2-73 (blarcamesine) met the main goal of improvement in cognitive function in patients with early Alzheimer's disease (AD) in a phase 2B ..."
publishedDateTime: 2022-12-02T12:15:00Z
originalUrl: "https://seekingalpha.com/news/3913461-anavex-drug-improves-cognitive-function-in-alzheimers-patients-meets-main-goal-of-trial"
webUrl: "https://seekingalpha.com/news/3913461-anavex-drug-improves-cognitive-function-in-alzheimers-patients-meets-main-goal-of-trial"
type: article

provider:
  name: Seeking Alpha
  domain: seekingalpha.com

topics:
  - Microsoft AI
  - AI

images:
  - url: "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1328955938/image_1328955938.jpg?io=getty-c-w750"
    width: 750
    height: 422
    isCached: true

secured: "G3N/Y4S3tjZCip12lHTQD6ChaKnP2bnf+1fGeWv2oXvVlUbFJjbIG2q+gbCjnGqlsSaD8OCcAw51x92f4ItaaKCLj3UwpJerKmTRzp8wDzP3JOS81aIRHmjokT8Uwzcx16ovTgUeiOiRW3ZOWWNYE0Q+4gVhdVIcXgM+EgIU/M4vXfsB/Vbc8gminOdyK5uRy9+xBHVj86JdAq/pTW9fn2gG07sCC6BfpYkiVvg0nfcPnCM1UoMX55Yqekcg7Zc34/ZQYkO4Yfud73Pc8hPJeupaxZttaVdMSnAFhy89FXDXGpEdRgy+H+Pw0GdKvs6vbHCiDoOhVGkN9GGfcV0ltrEVPn2FOfT05rCGyJNWwnU=;+1CvhHWRGlpPfEqrwdJ4kA=="
---

